Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation. by Yuan, S et al.
Journal Pre-proof
Obesity, Type 2 Diabetes, Lifestyle Factors and Risk of Gallstone Disease: A
Mendelian Randomization Investigation




To appear in: Clinical Gastroenterology and Hepatology
Accepted Date: 30 December 2020
Please cite this article as: Yuan S, Gill D, Giovannucci EL, Larsson SC, Obesity, Type 2 Diabetes,
Lifestyle Factors and Risk of Gallstone Disease: A Mendelian Randomization Investigation, Clinical
Gastroenterology and Hepatology (2021), doi: https://doi.org/10.1016/j.cgh.2020.12.034.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2021 by the AGA Institute
MR design
Genetic instruments for exposures 
obtained from GWASs
Summary-level data for gallstone disease
UK Biobank (10 520 cases and 350 674 controls)
FinnGen (11 675 cases and 121 348 controls)




















Obesity, Type 2 Diabetes, Lifestyle Factors and Risk of Gallstone Disease: A Mendelian 
Randomization Investigation 
 
Running head: Risk factors for gallstone disease 
 
Shuai Yuan,1 Dipender Gill,2-5 Edward L Giovannucci,6-8 Susanna C. Larsson1,9* 
 
1Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, 
Karolinska Institutet, Stockholm, Sweden 
2Department of Biostatistics and Epidemiology, School of Public Health, Imperial College London, 
London, United Kingdom 
3Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and 
Institute for Infection and Immunity, St George’s, University of London, London, United Kingdom 
4Clinical Pharmacology Group, Pharmacy and Medicines Directorate, St George’s University 
Hospitals NHS Foundation Trust, London, United Kingdom. 
5Novo Nordisk Research Centre Oxford, Old Road Campus, Oxford, United Kingdom 
6Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital 
and Harvard Medical School, Boston, MA, USA 
7Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA 
8Department of Nutrition, Harvard T H Chan School of Public Health, Boston, MA, USA 
9Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, 
Sweden 
 
*Corresponding author:  
Susanna C. Larsson, PhD, Associate professor 
Institute of Environmental Medicine, Karolinska Institutet, Nobelsväg 13, Stockholm, 17177, Sweden; 
Tel: 46-852486059; E-mail: susanna.larsson@ki.se 
 
Word count of abstract: 254 
Word count of text: 3916 (main text 2293 words, table and figure legends 553 words, references 1070 
words) 
Numbers of tables: 2 / figures: 3 
 
Abbreviations used in this paper: BMI, body mass index; CI, confidence interval; LD, linkage 











Disclosure / Conflict of interest declaration: All authors have completed the ICMJE 
uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from 
any organization for the submitted work. Other conflicts of interest are listed below. 
Dipender Gill is employed part-time by Novo Nordisk, outside of the submitted work.  
Financial support: The study is funded by the Swedish Research Council for Health, 
Working Life and Welfare (Forte; grant no. 2018-00123), the Swedish Research Council 
(Vetenskapsrådet; grant no. 2019-00977), and the Swdish Heart-Lung Foundation (Hjärt-
Lungfonden; grant no. 20190247). Dipender Gill is supported by the British Heart 
Foundation Research Centre of Excellence (RE/18/4/34215) at Imperial College London. 
Role of the Funder: Funders had no roles in the design and conduct of the study; collection, 
management, analysis, and interpretation of the data; preparation, review, or approval of the 
manuscript; or the decision to submit the manuscript for publication. 
Specific author contributors: Study conception and design: S.Y., D.G, E.L.G., S.C.L; data 
acquisition and analysis: S.Y.; drafting the manuscript and figures: S.Y.; reviewing the 
manuscript: S.Y., D.G, E.L.G., S.C.L. 
Guarantor of the article: S.C. Larsson, PhD 
Ethical approval: All studies had been approved by a relevant ethical review board and 
participants had given informed consent. 
Transparency declaration: The lead author (the manuscript’s guarantor) affirms that this 
manuscript is an honest, accurate, and transparent ccount of the study being reported; that no 
important aspects of the study have been omitted; an  that any discrepancies from the study 
as planned (and, if relevant, registered) have beenexplained. 
Acknowledgements: Genetic association estimates for gallstone disease were obtained from 
the UK Biobank and FinnGen consortium. The authors thank all investigators for sharing 
these data.  
Data sharing statement: The datasets analyzed in this study are publicly available summary 










Background & Aims Obesity, type 2 diabetes, and lifestyle factors (cigarette smoking, 
alcohol drinking, and coffee consumption) have been associated with the risk of developing 
gallstone disease in observational studies, but whether these associations are causal is 
undetermined. We conducted a Mendelian randomization study to assess these associations.  
Methods Genetic instruments associated with the exposures at the genome-wide significance 
(p<5×10−8) level were selected from corresponding genome-wide associations studies 
(n=224 459 to 1 232 091 individuals). Summary-level data for gallstone disease were 
obtained from the UK Biobank (10 520 cases and 350 674 non-cases) and FinnGen 
consortium (11 675 cases and 121 348 non-cases). Univariable and multivariable Mendelian 
randomization analyses were conducted. Results from UK Biobank and FinnGen were 
combined using fixed-effects meta-analysis.  
Results The odds ratios were 1.63 (95% confidence interval (CI), 1.49, 1.79) for one standard 
deviation (SD) increase in body mass index, 1.81 (95% CI, 1.60, 2.05) for one SD increase in 
waist circumference, 1.13 (95% CI, 1.09, 1.17) for one unit increase in the log-odds ratio of 
type 2 diabetes and 1.25 (95% CI, 1.16, 1.34) for one SD increase in prevalence of smoking 
initiation. The associations for body mass index and type 2 diabetes persisted after mutual 
adjustment. Genetically predicted coffee consumption was inversely associated with 
gallstone disease after adjustment for body mass index and smoking (odds ratio per 50% 
increase 0.44, 95% CI, 0.21, 0.91). There was no association withalcohol consumption.  
Conclusions This study supports independent causal roles of obesity, type 2 diabetes, and 
smoking in gallstone disease.  
 









Gallstone disease affects around 10% to 20% of the global adult population and is associated 
with the highest socioeconomic costs of all gastroin estinal conditions.1-3 Serious 
complications, such as cholecystitis, cholangitis, and pancreatitis, as well as gallstone 
recurrence influence health status and quality of life of gallstone patients after 
cholecystectomy.4 Obesity,1, 2, 4 type 2 diabetes5-7 and cigarette smoking8 have been proposed 
as risk factors, and alcohol4, 9, 10 and coffee4, 11, 12 consumption as protective factors for 
gallstones in traditional observational studies. However, the causality of these observational 
findings cannot be determined as residual confounding may have biased the results. For 
example, obesity and type 2 diabetes are closely interrelated and their independent 
association with cholelithiasis is uncertain. Likewise, cigarette smoking, alcohol drinking, 
and coffee consumption are overlapping behaviors,13 and this may introduce residual 
confounding in observational studies.  
Mendelian randomization (MR) leverages the random alloc tion of genetic variants 
during conception as instrumental variables to estimate the causal association between an 
exposure (e.g., body mass index (BMI)) and health ou come.14 Here, the MR design was used 
to assess the potential causal associations of overall obesity (measured as BMI), abdominal 
obesity (measured as waist circumference), type 2 diabetes, and lifestyle factors (cigarette 
smoking, alcohol drinking, and coffee consumption) with risk of gallstone disease.  
 
Methods 
Study design and data sources 
Study design overview and the assumptions of a Mendelian randomization study are shown 
in Figure 1. Genetic instruments for the exposures were obtained from published genome-









and the FinnGen consortium21. Detailed information on used data sources is displayed in 
Table 1. All studies had been approved by a relevant ethical review board and participants 
had given informed consent. 
 
Genetic instrument selection 
Genetic instruments for BMI15, waist circumference (with and without adjustment for BMI)16, 
cigarette smoking17, alcohol drinking17, coffee consumption18, and type 2 diabetes19 were 
selected at genome-wide significance threshold (p <5×10−8) from corresponding genome-
wide association studies. A set of genetic instruments associated with smoking index22 
(taking into account smoking status as well as smoking duration, heaviness, and cessation in 
ever smokers) were used in a supplementary analysis. Linkage disequilibrium (LD) among 
single-nucleotide polymorphisms (SNPs) for each risk factor was calculated based on 1000 
genomes LD reference panel (European population) using the PLINK clumping method. 
SNPs in LD (r2>0.01 and clump window <10 kb) were excluded and the SNP with the lowest 
p-value was retained. In the analysis of coffee consumption, five SNPs were excluded due to 
pleiotropic associations with other potential risk factors (in particular BMI) at genome-wide 
significance (rs1260326 in the GCKR gene, rs574367 in SEC16B, rs10865548 in TMEM18, 
rs66723169 in MC4R, and rs34060476 in MLXIPL).23 
 
Data sources for gallstone disease  
Summary-level genetic data for gallstone disease (cholelithiasis, defined by the International 
Classification of Diseases 10th Revision code K80) were obtained from the UK Biobank 
cohort20 and the FinnGen consortium21. The second wave of analyses of UK Biobank from 
Neale lab was used in the present study. Data from Neale lab included 361 194 UK Biobank 









individuals (or at least one of a related pair of individuals), individuals with sex chromosome 
aneuploidies, and individuals who had withdrawn consent from the UK Biobank study. 
Association tests had been adjusted for age, sex and up to 20 principal components. The R3 
release of the FinnGen consortium data was used. In that dataset, individuals with ambiguous 
gender, high genotype missingness (>5%), excess heterozygosity (±4 standard deviation) and 
non-Finnish ancestry had been excluded. Association tests had been adjusted for age, sex, 10 
genetic principal components and genotyping batch.  
 
Statistical analysis 
The multiplicative random-effects inverse-variance w ighted model was used to obtain the 
MR estimates. Derived estimates based on UK Biobank and the FinnGen consortium were 
combined using fixed-effects meta-analysis. Multivariable random-effects inverse-variance 
weighted model was used to adjust for BMI in the analysis of type 2 diabetes and vice versa. 
We also conducted a two-step multivariable MR analysis in the analysis of coffee 
consumption to adjust for BMI and smoking initiation. Likewise, multivariable MR analysis 
was performed to adjust for smoking initiation in the analysis of alcohol drinking as these 
two traits are genetically correlated (rg=0.34)
17. Three other methods, including the weighted 
median, MR-Egger regression and MR-PRESSO methods, were used as sensitivity analyses. 
The weighted median model provides consistent estimates on the condition that ≥50% of the 
weight in the analysis comes from valid instrumental v riables.24 MR-Egger regression 
analysis can detect and correct for directional pleiotropy whereas it compromises power.25 
The p value for the MR-Egger intercept was used to indicate directional pleiotropy. The MR-
PRESSO approach can detect outliers and generate estimates after outliers removing.26 The 
MR-PRESSO distortion test aims at examining the differences between the estimates before 









estimates before and after outlier correction.26 Cochrane’s Q value was estimated to assess 
the heterogeneity among used SNPs for each risk factor. Odds ratios (ORs) and 
corresponding confidence intervals (CIs) of gallstone disease were scaled to one standard 
deviation (SD) increase in BMI and waist circumferenc , one unit increase in log-odds ratio 
of type 2 diabetes, one SD increase in prevalence of sm king initiation, one SD increase of 
lifetime smoking index, one SD increase of log-transformed alcoholic drinks/week, and 50% 
increase in coffee consumption, respectively. All analyses were performed using the 




Genetically predicted higher BMI, waist circumferenc , and liability to type 2 diabetes were 
associated with elevated risk of gallstone disease in UK Biobank, FinnGen and meta-analysis 
(p<0.001) (Figure 2 and Figure 3). The combined ORs of gallstones were 1.63 (95% CI, 
1.49, 1.79) per one SD increase in BMI, 1.81 (95% CI, 1.60, 2.05) per one SD increase in 
waist circumference, and 1.13 (95% CI, 1.09, 1.17) for one unit increase in log-odds ratio of 
type 2 diabetes. The associations were consistent in all sensitivity analyses, though pleiotropy 
was detected in the analysis of type 2 diabetes in UK Biobank by the MR-Egger regression. 
After removing outliers in the MR-PRESSO analysis, the association between type 2 diabetes 
and cholelithiasis persisted and the p value for the distortion test were above 0.05 (Table 2). 
Associations for BMI and type 2 diabetes persisted an  attenuated slightly after mutual 
adjustment (Figure 2). The association between genetically predicted waist circumference 
and gallstone disease did not remain in UK Biobank, d attenuated greatly in FinnGen after 









Among lifestyle factors, genetic predisposition to smoking initiation was associated 
with gallstones in the meta-analysis of data from UK Biobank and FinnGen (OR 1.25; 95% 
CI, 1.16, 1.34, for one SD increase in smoking preval nce) (Figure 3 and Table 2). This 
positive association was replicated in the sensitivity analysis of lifetime smoking index. 
There were no associations of alcohol or coffee consumption with gallstones in the primary 
analysis (Figure 3) or the sensitivity analyses of each data source (Table 2). After adjustment 
for BMI, coffee consumption showed an inverse associati n with gallstones (OR 0.50; 95% 
CI, 0.29, 0.88, per 50% increase in coffee consumption). This association remained after 
additional adjustment for smoking initiation (OR 0.44; 95% CI, 0.21, 0.91). In meta-analysis 
of estimates from UK Biobank and FinnGen, coffee consumption showed an association with 
gallstones in analysis based on the weighted median method with OR of 0.78 (95% CI, 0.63, 
0.97). Genetically predicted alcohol drinking (the combined OR 1.06; 95% CI, 0.77, 1.47) 




The present MR study supports that both obesity and type 2 diabetes are independently and 
causally associated with the risk of gallstone disease. Moreover, our results provide support 
for a causal association between smoking and risk of gallstone disease. A possible causal 
association is observed between high coffee consumption and decreased risk of gallstone 
disease. There is no evidence that alcohol drinking is causally associated with gallstones.  
BMI, representing overall obesity, has been associated with gallstones in 
observational studies4, 29 and in a one-sample MR study in 77 679 Danish adults,30 which was 
corroborated by the present two-sample MR analysis in British and Finnish populations. The 









BMI, which indicated that central obesity is not a more important risk factor than overall fat 
mass for gallstone disease. The association between ob sity and gallstones was slightly 
attenuated in the multivariable MR analysis with adjustment for genetically predicted type 2 
diabetes liability, which may suggest that type 2 diabetes partly mediates this association. 
Several mechanisms, including alterations of metabolic factors, hepatic secretion of 
supersaturated bile, dyslipidemia, intestinal and gallbladder hypomotility, gallbladder stasis, 
decreased secretion of bile acids, cholesterol crystallization and precipitation, and 
supersaturated gallbladder bile, may underlie the increased risk of gallstones among obese 
individuals.31 Even though obesity plays a causal role in the development of gallstones, both 
bariatric and a low-calorie diet have been shown to increase the risk of asymptomatic and 
symptomatic gallstones.32, 33 Such increased risk might be related to a rapid weight loss.34  
Studies of the association of type 2 diabetes with risk of gallstones have not been 
entirely consistent. A meta-analysis of 10 cohort studies showed an overall 56% increased 
risk of gallstones among diabetes patients compared with individuals without diabetes7. An 
increased risk of gallstones in type 2 diabetes patients was also found in a cross-sectional 
study with more than 4 million diabetes patients6, but not in several other case-control 
studies5, 35. In one of those case-control studies, type 2 diabetes was associated with 
gallstones in the univariable (crude) analysis, butthe association was attenuated after 
adjustment for obesity and other risk factors35. The present MR study based on a large 
number of gallstone disease cases revealed a possibly causal association between type 2 
diabetes and gallstones and the association was likely independent of BMI. Several possible 
mechanisms may explain the association between type 2 diabetes and gallstone disease. For 
example, hepatic insulin resistance has been shown t  directly promote the formation of 
cholesterol gallstones.36 Gallbladder hypomotility in diabetes might be an additional 









Epidemiological data on the association between cigarette smoking and gallstones are 
inconsistent with positive8, 37 and null findings38 reported. Our study provided evidence to 
support a causal role of cigarette smoking in the development of gallstone and further that the 
association is likely independent of BMI. The different effect sizes of smoking on gallstones 
in UK Biobank and FinnGen might be related to differences in smoking patterns. Meta-
analyses on alcohol consumption in relation to gallstones revealed a dose-response inverse 
relationship9, 10 and a J-shaped association (the risk of gallstones decreased with increasing 
alcohol consumption up to 30 g/day and thereafter plateaued)10. However, our study did not 
confirm the inverse association4, 9, but could not rule out a possible weak non-linear 
association of alcohol drinking with gallstones.  
With regard to coffee consumption, an inverse associati n with risk of overall and 
symptomatic gallstone disease has been found in observational studies4, 11, 12 and in a one-
sample MR study based on 114 220 Danish individuals (including 7294 cases)39. The present 
MR study supported a possible association between high coffee consumption and lower risk 
of gallstones. Potential mechanisms underlying this inverse association might be that 
components in coffee stimulate cholecystokinin release, enhance gallbladder motility, inhibit 
gallbladder fluid absorption, decrease cholesterol c ystallization in bile, down-regulate the 
hepatic low density lipoprotein receptor and decrease 3-hydroxyl-3-methylglutaryl Co A 
reductase activity.40  
The major strengths of the present study are the MR design and the large number of 
gallstone disease cases. The similar results in two independent populations supported the 
robustness and reliability of our results for the associations of obesity and type 2 diabetes 
with gallstones. Genetic associations with the International Classification of Diseases-defined 
gallstone endpoint in UK Biobank has been replicated in both Icelandic and Danish cohorts,41, 








stratification bias is unlikely to have influenced our results as the majority of recruited 
participants in the genome-wide association studies w re of European origin and adjustment 
was made for population structure through genetic pr ncipal components. However, this 
population confinement might also limit the generalizability of our findings to other 
populations.  
A limitation of the present study is that we could not distinguish between cholesterol 
and pigment gallstones, which have different etiologies. Nevertheless, the vast majority of 
gallstones in the Western world are cholesterol gallstones.  
A potential concern in any MR study is pleiotropy. There are two types of pleiotropy 
in MR studies – vertical and horizontal pleiotropy.43, 44 In this study, genetic instruments for 
BMI influenced the risk of gallstone disease partly via type 2 diabetes, which would represent 
vertical pleiotropy (or mediated pleiotropy) as BMI was a causal risk factor for type 2 
diabetes.45 Vertical pleiotropy is not a barrier in causal inference of MR studies.43, 44 The 
genetic instruments for coffee consumption had moderate correlations with BMI and 
smoking.18 Given that coffee consumption is less likely to cause obesity and smoking 
initiation, this phenomenon called horizontal pleiotropy would bias causal estimation. We 
found an inverse association between genetically predicted coffee consumption and 
gallstones after removal of pleiotropy by excluding pleiotropic genetic variants and after 
adjusting for BMI and smoking through multivariable MR analysis.43, 44 Considering the 
consistent associations of genetic predisposition to type 2 diabetes and smoking initiation 
with gallstone disease across the two data sources and different MR models, these results are 
unlikely to be driven by horizontal pleiotropy.  
In conclusion, the present study provides MR evidence supporting causal roles of 
obesity, type 2 diabetes and cigarette smoking in gallstones. The possible association 
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Figure 1. Study design overview and assumptions of the Mendelian randomization design. 
BMI, body mass index; IVW, inverse-variance weighted; LD, linkage disequilibrium; SNP, 
single-nucleotide polymorphisms; T2DM, type 2 diabetes mellitus; WC, waist circumference.  
Assumption 1 indicates that the genetic variants proposed as instrumental variables should be 
robustly associated with the risk factor of interest; assumption 2 indicates that the used 
genetic variants should not be associated with potential confounders, and assumption 3 
indicates that the selected genetic variants should affect the risk of the outcome merely 
through the risk factor, not via alternative pathways. The Mendelian randomization design 
can reduce residual confounding and reverse causality, thereby reinforcing the causal 
inference of an exposure-outcome association. The basis of this is that genetic variants, 
selected as instrumental variable for studying the eff ct of modifying the exposure, are 
randomly allocated at conception and are therefore less vulnerable to confounding from 
environmental factors and reverse causation. 
 
Figure 2. Associations of body mass index and type 2 diabetes with gallstone disease in 
univariable and multivariable Mendelian randomization analyses. CI, confidence interval; 
IVW, inverse-variance weighted; OR, odds ratio; UKBB, UK Biobank. The multivariable 
MR analysis adjusted for type 2 diabetes in the analysis of body mass index and vice versa. 
The ORs of gallstone disease were scaled to one stadard deviation increase in body mass 
index and one unit increase in log-odds ratio of type 2 diabetes.  
 
Figure 3. Associations of genetically predicted waist circumference and modifiable lifestyle 
factors with gallstone disease*. BMI indicates body mass index; CI, confidence interval; OR, 
odds ratio; UKBB, UK Biobank. Estimates for coffee consumption with adjustment for BMI 
were derived from the multivariable inverse-variance weighted model with random effects. 
The ORs of gallstone disease were scaled to one standard deviation increase in waist 
circumference, one standard deviation increase in prevalence of smoking initiation, one 
standard deviation increase of lifetime smoking index, one standard deviation increase of log-
transformed alcoholic drinks/week and 50% increase in coffee consumption. *Estimates were 
derived using the multiplicative random-effects inverse-variance weighted Mendelian 













Unit Participants included in 
analysis Adjustments 
Identified 
SNPs  PubMed ID or web-link 
BMI SD 339 224 individuals of multi-
ancestries 
Age and any necessary study-
specific covariates 
97 25673413 
Waist circumference SD 224 459 individuals of 
European ancestry 
Age and study-specific covariates 47 25673412 
Waist circumference 
adjusted for BMI 
SD 224 459 individuals of 
European ancestry 
Age, body mass index and study-
specific covariates 
70 25673412 
Type 2 diabetes One-unit in log-
odds ratio of type 
2 diabetes 
228 499 type 2 diabetes cases 
and 1 178 783 non-cases of 
multi-ancestries 
Age, sex, and the first ten genetic 
principal components 
558 32541925 

















Genotyping chip and sex 
 
126 31689377 




941 280 European-descent 
individuals 





Coffee consumption 50% change 375 833 European-descent 
individuals 
Age, sex, body mass index, total 
energy, proportion of typical food 




Gallstone disease* - 10 520 gallstone disease cases 
and 350 674 non-cases 
Age, sex and up to 20 genetic 
principal components 
- UK Biobank 
(http://www.nealelab.is/uk-
biobank) 
Gallstone disease* - 11 675 gallstone disease cases 
and 121 348 non-cases 
Age, sex, 10 genetic principal 
components and genotyping batch 
- FinnGen consortium 
(https://www.finngen.fi/fi) 
 
BMI indicates body mass index; SD, standard deviation; SNPs, single-nucleotide polymorphism. *Defined by the International Classification of Diseases 



















 OR 95% CI P OR 95% CI P OR 95% CI P 
UK Biobank               
BMI 93 91.79 1.53 1.26, 1.85 1.75×10-5 1.50 1.12, 2.00 0.008 1.61 1.43, 1.81 5.52×10-12 0.591 0.554 
Waist circumference 45 45.69 1.48 1.15, 1.91 0.003 1.74 1.14, 2.68 0.015 1.64 1.40, 1.92 2.42×10-7 0.763 0.433 
Waist circumference 
adjusted for BMI 
70 105.77 1.06 0.86, 1.31 0.579 1.16 0.56, 2.39 0.687 0.99 0.84, 1.18 0.937 0.003 0.665 
Type 2 diabetes  488 707.89 1.10 1.04, 1.17 0.001 1.02 0.94, 1.11 0.592 1.12 1.08, 1.17 2.47×10-8 0.009 0.709 
Smoking initiation 309 406.80 1.30 1.14, 1.48 7.60×1 -5 1.10 0.72, 1.69 0.666 1.39 1.25, 1.54 9.10×10-10 0.253 0.841 
Lifetime smoking index 126 164.77 1.58 1.20, 2.07 0.001 0.62 0.28, 1.39 0.251 1.56 1.28, 1.89 1.85×10-5 0.016 0.569 
Alcohol drinking 82 240.89 1.00 0.60, 1.65 0.995 1.09 0.45, 2.68 0.848 1.07 0.79, 1.46 0.654 0.662 0.050 
Coffee consumption 9 27.10 0.81 0.57, 1.15 0.248 0.76 0.37, 1.58 0.488 0.99 0.77, 1.28 0.953 0.829 <0.001 
FinnGen              
BMI 93 122.80 1.74 1.40, 2.18 1.06×10-6 2.09 1.45, 3.01 1.63×10-4 1.62 1.40, 1.87 4.86×10-9 0.189 0.730 
Waist circumference 45 66.74 2.27 1.76, 2.93 3.44×10-10 3.08 1.79, 5.30 2.13×10-4 2.05 1.69, 2.48 5.60×10-9 0.163 0.662 
Waist circumference 
adjusted for BMI 
70 116.12 1.31 1.03, 1.65 0.027 0.70 0.30, 1.63 0.420 1.23 1.01, 1.49 0.037 <0.001 0.188 
Type 2 diabetes  468 761.75 1.10 1.03, 1.18 0.008 1.11 1.00, 1.22 0.044 1.12 1.07, 1.17 1.40×10-6 0.636 0.620 
Smoking initiation 295 333.40 1.11 0.96, 1.29 0.160 0.83 0.53, 1.30 0.414 1.09 0.98, 1.22 0.100 0.214 NA 
Lifetime smoking index 124 178.11 1.14 0.84, 1.55 0.411 0.29 0.11, 0.77 0.015 1.23 0.97, 1.57 0.096 0.004 NA 
Alcohol drinking 78 193.20 0.97 0.57, 1.65 0.918 0.60 0.17, 2.13 0.434 0.87 0.59, 1.26 0.459 0.697 0.754 
Coffee consumption 9 16.86 0.77 0.59, 1.02 0.066 0.78 0.39, 1.54 0.495 0.82 0.66, 1.02 0.118 0.697 0.620 
 
BMI, indicates body mass index; CI, confidence interval; NA, not available; OR, odds ratio; SNPs, single-nucleotide polymorphisms. The ORs of gallstone 
disease were scaled to one standard deviation increase in BMI and waist circumference, one unit increase in log-odds ratio of type 2 diabetes, one standard 
deviation increase in prevalence of smoking initiation, one standard deviation increase of lifetime smoking index, one standard deviation increase of log-
transformed alcoholic drinks/week and 50% increase in coffee consumption. 
aP values for pleiotropy were derived from MR-Egger test and a p value < 0.05 indicates a possible pleiotropic effect.  
bP values for distortion were derived from MR-PRESSO test and a p v lue < 0.05 indicates a difference between estimates before and after outlier removal. P 
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OR (95% CI) of cholelithiasis
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What You Need To Know 
Background 
Obesity, type 2 diabetes, and lifestyle factors have been associated with the risk of 
developing gallstone disease in observational studies, but whether these associations are 
causal is undetermined. 
Findings 
Genetic predisposition to obesity, type 2 diabetes and smoking initiation was associated with 
an increased risk of gallstone disease. Genetically predicted coffee consumption but not 
alcohol consumption was associated with a reduced risk of gallstone disease.  
Implications for patient care 
Preventing obesity and diabetes and modifying lifestyle factors may act as prevention 
strategies for gallstone disease.  
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